SYNTHETIC ANTISENSE OLIGONUCLEOTIDES - PRINCIPLES AND ANTILEUKEMIC ACTIVITY

Citation
S. Morelli et al., SYNTHETIC ANTISENSE OLIGONUCLEOTIDES - PRINCIPLES AND ANTILEUKEMIC ACTIVITY, Oncology Reports, 4, 1997, pp. 219-225
Citations number
20
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
4
Year of publication
1997
Supplement
1
Pages
219 - 225
Database
ISI
SICI code
1021-335X(1997)4:<219:SAO-PA>2.0.ZU;2-1
Abstract
Inhibition of gene expression by antisense oligonucleotides relies on the ability of an ODN to bind a complementary messenger RNA sequence a nd prevent translation of the mRNA. Most human follicular B cell lymph omas are associated with t(14;18) chromosome translocation that joins the bcl-2 gene with the IgH locus. This hybrid gene causes upregulatio n of the BCL-2 protein expression, endowing cells with survival advant age. The capacity of oligonucleotides to modulate gene expression spec ifically has been exploited to down regulate the overexpression of BCL -2 protein in the SU-DHL-4 human follicular B cell lymphoma line by ta rgeting the hybrid transcript with ODN encompassing the unique nucleot ide sequence in the fusion region.